Norway· NO-ID_FBB3880C-DB93-4209-BE13-92E8F33FED80
Raploc
A landiolol product containing landiolol hydrochloride, registered in Norway by Amomed Pharma GmbH. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Landiolol is registered in 15 of 19 countries.
Countries holding a registration under ATC C07AB14 (landiolol), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Landiolol · ATC C07AB14
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Landiolol Hydrochloride
- Manufacturer
- Amomed Pharma GmbH
- Country
- Norway (NO)
- ATC code
- C07AB14
- ATC class
- Landiolol
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_FBB3880C-DB93-4209-BE13-92E8F33FED80
- no_varenummer467802300NOK 4020.7
- gtin9120093140481
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Landiolol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRAPIBLOCAmomed Pharma GmbH, Vídeň
- SwitzerlandRapibloc 300 mg, Pulver zur Herstellung einer InfusionslösungOrPha Swiss GmbH
- BelgiumRunrapiq 300 mgOrpha-Devel Handels und Vertriebs
- United KingdomRapibloc 300mg powder for solution for infusion vialsAOP Orphan Ltd
- IrelandRapibloc 300 mg powder for solution for infusionOrpha-Devel Handels und Vertriebs GmbH
- PolandRunrapiqAmomed Pharma GmbH
- SpainRAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSIONOrpha-Devel Handels Und Vertriebs Gmbh
- Japanランジオロール塩酸塩小野薬品工業
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Rapibloc
- Belgium · Runrapiq
- Bulgaria · Рапиблок
- Cyprus · Rapibloc
- Czechia · Rapibloc
- Germany · Rapibloc
- Denmark · Rapibloc
- Estonia · Raploc
- Spain · Rapibloc
- Finland · Rapibloc
- France · Rapibloc
- Greece · Rapibloc
- Croatia · Rapibloc
- Hungary · Rapibloc
- Ireland · Rapibloc
- Italy · Landiobloc
- Lithuania · Raploc
- Latvia · Raploc
- Netherlands · Landiolol Hydrochloride Orpha-Devel, Rapibloc
- Poland · Runrapiq
- Portugal · Rapibloc
- Romania · Rapibloc
- Sweden · Rapibloc
- Slovenia · Rapibloc
- Slovakia · Rapibloc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9e2947f-ff8a-4ef0-831a-d961784b364b GET /v1/drugs/d9e2947f-ff8a-4ef0-831a-d961784b364b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Landiolol",
"merkevare_id": "ID_FBB3880C-DB93-4209-BE13-92E8F33FED80",
"name_form_strength": "Raploc pulv til inf væske oppl 300 mg",
"prescription_group": "C"
}See everything about landiolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.